MOTYS IND is Filed, Sales Training Begins

MOTYS IND is Filed, Sales Training Begins


Read More

2 Million Treatments Worldwide with DUROLANE

2 Million Treatments Worldwide with DUROLANE It may be hard to believe, but Bioventus is celebrating a milestone and recognizing…


Read More

SIGNAFUSE Bioactive Bone Graft Strips See Early Adoption by Surgeon in Virginia

SIGNAFUSE Bioactive Bone Graft Strips See Early Adoption by Surgeon in Virginia Launched just weeks ago, Bioventus Surgical is…


Read More

Waking Up Those Sleeping Customers in Europe

Waking Up Those Sleeping Customers in Europe As the global pandemic continued into spring, the EMEA Customer Care and Internal…


Read More

Bioventus Makes $15 Million Equity Investment in CartiHeal

Bioventus Makes $15 Million Equity Investment in CartiHeal with an Agreed Option Structure to Acquire Company Upon Milestone…


Read More

SIGNAFUSE Bioactive Bone Graft in Strip Format Receives FDA Clearance

SIGNAFUSE Bioactive Bone Graft in Strip Format Receives FDA Clearance The SIGNAFUSE Bioactive Bone Graft has been available as a…


Read More

Health Screening Survey Made Easier to Find in Workday

Health Screening Survey Made Easier to Find in Workday Employees returning to work, we are happy to announce an updated process…


Read More

Getting Back to the New Normal at Bioventus

Getting Back to the New Normal at Bioventus “The Surgical Team and the AHT Sales Team in Germany are doing phenomenal, already…


Read More

Updated Return to Work Guidance for the US

Updated Return to Work Guidance for the US Offices Bioventus is in the process of returning to our new normal with our field…


Read More

Return to Work Guidance for Bioventus

Return to Work Guidance for Bioventus Our number one priority through this pandemic continues to be keeping our employees safe…


Read More